These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide. de Jong JW; van der Mark TW; Koëter GH; Postma DS Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165 [TBL] [Abstract][Full Text] [Related]
27. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Chishimba L; Niven RM; Cooley J; Denning DW J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765 [TBL] [Abstract][Full Text] [Related]
28. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Laoudi Y; Paolini JB; Grimfed A; Just J Eur Respir J; 2008 Apr; 31(4):908-9. PubMed ID: 18378789 [No Abstract] [Full Text] [Related]
29. Allergic bronchopulmonary aspergillosis: it's here in South Carolina. Imbeau SA J S C Med Assoc; 2006 Jun; 102(5):126-8. PubMed ID: 17315519 [No Abstract] [Full Text] [Related]
30. Coexisting atopic conditions influence the likelihood of allergic bronchopulmonary aspergillosis in asthma. Tay TR; Bosco J; Gillman A; Aumann H; Stirling R; O'Hehir R; Hew M Ann Allergy Asthma Immunol; 2016 Jul; 117(1):29-32.e1. PubMed ID: 27234940 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). Chishimba L; Langridge P; Powell G; Niven RM; Denning DW J Asthma; 2015 Apr; 52(3):289-95. PubMed ID: 25158109 [TBL] [Abstract][Full Text] [Related]
32. Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation. Kumar R Chest; 2003 Sep; 124(3):890-2. PubMed ID: 12970013 [TBL] [Abstract][Full Text] [Related]
34. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients. Tanimoto H; Fukutomi Y; Yasueda H; Takeuchi Y; Saito A; Watai K; Sekiya K; Tsuburai T; Asano K; Taniguchi M; Akiyama K Clin Exp Allergy; 2015 Dec; 45(12):1790-800. PubMed ID: 26118958 [TBL] [Abstract][Full Text] [Related]
35. The management of allergic bronchopulmonary aspergillosis. Wang JL; Patterson R; Roberts M; Ghory AC Am Rev Respir Dis; 1979 Jul; 120(1):87-92. PubMed ID: 464387 [TBL] [Abstract][Full Text] [Related]
37. Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis. Agarwal R; Dua D; Choudhary H; Aggarwal AN; Sehgal IS; Dhooria S; Garg M; Behera D; Chakrabarti A Mycoses; 2017 Jan; 60(1):33-39. PubMed ID: 27523578 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Agarwal R; Gupta D; Aggarwal AN; Saxena AK; Saikia B; Chakrabarti A; Jindal SK Respir Med; 2010 Feb; 104(2):204-10. PubMed ID: 19800210 [TBL] [Abstract][Full Text] [Related]
39. Use of budesonide in severe asthmatics aged 1-3 years. Connett GJ; Warde C; Wooler E; Lenney W Arch Dis Child; 1993 Sep; 69(3):351-5. PubMed ID: 8215545 [TBL] [Abstract][Full Text] [Related]